1. Diagnostic Accuracy of Nipple Discharge Fluid Cytology: A Meta-Analysis and Systematic Review of the Literature
    Natasha Jiwa et al, 2022, Annals of Surgical Oncology CrossRef
  2. Diagnostic Accuracy of Nipple Aspirate Fluid Cytology in Asymptomatic Patients: A Meta-analysis and Systematic Review of the Literature
    Natasha Jiwa et al, 2021, Annals of Surgical Oncology CrossRef
  3. Breast health screening: a UK-wide questionnaire
    Natasha Jiwa et al, 2021, BMJ Nutrition, Prevention & Health CrossRef
  4. Blood and urine biomarkers in invasive ductal breast cancer: Mass spectrometry applied to identify metabolic alterations
    Dan Tudor Eniu et al, 2022, Journal of Molecular Structure CrossRef
  5. New horizon for breast cancer biomarker discoveries: What might the liquid biopsy of nipple aspirate fluid hold?
    Ferdinando Mannello, 2017, PROTEOMICS – Clinical Applications CrossRef
  6. Biomineralogical signatures of breast microcalcifications
    Jennie A. M. R. Kunitake et al, 2023, Science Advances CrossRef
  7. Biomarker Reproducibility Challenge: A Review of Non-Nucleotide Biomarker Discovery Protocols from Body Fluids in Breast Cancer Diagnosis
    Fatemeh Safari et al, 2023, Cancers CrossRef
  8. Development of suspension cell culture model to mimic circulating tumor cells
    Ji Young Park et al, 2018, Oncotarget CrossRef
  9. Current Status and Future Prospects of Clinically Exploiting Cancer-specific Metabolism—Why Is Tumor Metabolism Not More Extensively Translated into Clinical Targets and Biomarkers?
    Magesh Muthu et al, 2019, International Journal of Molecular Sciences CrossRef
  10. Breast Cancer Biomarkers in Proximal Fluids
    Gabriel D. Dakubo, 2019, Cancer Biomarkers in Body Fluids CrossRef
  11. Lipids as Biomarkers of Cancer and Bacterial Infections
    Gerald Larrouy-Maumus, 2019, Current Medicinal Chemistry CrossRef
  12. Evaluation of nipple aspirate fluid as a diagnostic tool for early detection of breast cancer
    Sadr-ul Shaheed et al, 2018, Clinical Proteomics CrossRef
  13. Breast cancer, screening and diagnostic tools: All you need to know
    Diego Barba et al, 2021, Critical Reviews in Oncology/Hematology CrossRef
  14. The Relevance of Mass Spectrometry Analysis for Personalized Medicine through Its Successful Application in Cancer “Omics”
    Cristina Alexandra Ciocan-Cartita et al, 2019, International Journal of Molecular Sciences CrossRef
  15. Metabolomics in breast cancer: A decade in review
    Amelia McCartney et al, 2018, Cancer Treatment Reviews CrossRef
  16. Metabolomic Analysis of Plasma from Breast Cancer Patients Using Ultra-High-Performance Liquid Chromatography Coupled with Mass Spectrometry: An Untargeted Study
    Patricia A. Da Cunha et al, 2022, Metabolites CrossRef
  17. Differentially expressed gene profile and relevant pathways of the traditional Chinese medicine cinobufotalin on MCF‑7 breast cancer cells
    Jie Li et al, 2019, Molecular Medicine Reports CrossRef
  18. Network-Based Approach to Identify the Antiproliferative Mechanisms of Bruceine D in Breast Cancer From the Cancer Genome Atlas
    Saisai Tian et al, 2020, Frontiers in Oncology CrossRef
  19. INTEND II randomized clinical trial of intraoperative duct endoscopy in pathological nipple discharge
    G Gui et al, 2018, British Journal of Surgery CrossRef
  20. Metabolomic study of serum in patients with invasive ductal breast carcinoma with LC-MS/MS approach
    Nasrin Amiri-Dashatan et al, 2022, The International Journal of Biological Markers CrossRef